Clinical Trials
5 trialsNCT00970541 2021-08-25
Eccentric
Pennington Biomedical Research Center
Phase 1 Terminated
NCT03119077 2018-05-17
Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116
Bayer
Phase 1 Terminated
NCT01489319 2017-02-10
ELI-ROAS
Indiana University
Phase 1 Terminated
NCT00823420 2014-12-05
Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential
Universitair Ziekenhuis Brussel
Phase 1 Terminated
NCT00822874 2014-12-03
Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential
Universitair Ziekenhuis Brussel
Phase 1 Terminated